{"id":8,"date":"2013-03-19T09:21:01","date_gmt":"2013-03-19T01:21:01","guid":{"rendered":"http:\/\/wp.kmu.edu.tw\/yeloch\/?page_id=8"},"modified":"2013-03-19T09:46:14","modified_gmt":"2013-03-19T01:46:14","slug":"%e7%a0%94%e7%a9%b6%e8%91%97%e4%bd%9c","status":"publish","type":"page","link":"https:\/\/wp.kmu.edu.tw\/yeloch\/%e7%a0%94%e7%a9%b6%e8%91%97%e4%bd%9c\/","title":{"rendered":"\u7814\u7a76\u8457\u4f5c"},"content":{"rendered":"

2013<\/b><\/p>\n

    \n
  1. Chen YL, <\/b>Tseng CH, Lo YC, <\/b>Lin RW, Chen CF, Wang GJ, Ho ML, Tzeng CC \u201cSynthesis of aminoalkoxy substituted 4,5-diphenylisoxazole derivatives as potential anti-osteoporotic agents<\/a>\u201d Med, Chem.<\/i> 2013<\/b>, in pressed. (SCI, IF2011<\/sub> = 1.496, 42\/59 = 71.2%)<\/li>\n
  2. Lin KL, Chien CM, Tseng CH, Chen YL<\/b>, Chang LS, Lin SR \u201cFurano-1,2-Naphthoquinone Inhibits src and pi3k\/akt Signaling Pathways in ca9-22 Human Oral Squamous Carcinoma Cells<\/a>\u201d Integr. Cancer Ther. <\/i>2012<\/b>,<\/i> in pressed. (SCI, IF2011<\/sub> = 2.136, 6\/22 = 27.3%)<\/li>\n
  3. Tseng CH, Cheng CM, Tzeng CC, Peng SI, Yang CL, Chen YL*<\/b> \u201cSynthesis and Anti-inflammatory Evaluations of \u03b2-Lapachone Derivatives<\/a>\u201d, Bioorg. Med. Chem.<\/i> <\/b>2013<\/b>, 21<\/i>, 523-531. (SCI, IF2011<\/sub> = 2.921; R\/C = 21\/59, CHEMISTRY, MEDICINAL)<\/li>\n
  4. Hsieh CY, Tsai PC, Tseng CH, Chen YL, Chang LS, Lin SR* \u201cInhibition of EGF\/EGFR activation with naphtho[1,2-b]furan-4,5-dione blocks migration and invasion of MDA-MB-231 cells<\/a>\u201d Toxicology in Vitro, <\/i>2013,<\/b> 27, <\/i>1-10. <\/i><\/li>\n
  5. Tseng CH, Chen YL, <\/b>Hsu CY, Chen TC, Cheng CM, Tso HC, Lu YJ, Tzeng CC* \u201cSynthesis and antiproliferative evaluation of 3-phenylquinolinylchalcone derivatives against non-small cell lung cancers and breast cancers<\/a>\u201d Eur. J. Med. Chem.<\/i> <\/b>2013<\/b>, 59<\/i>, 274-282. (SCI, IF2011<\/sub> = 3.346; R\/C = 13\/59, CHEMISTRY, MEDICINAL)<\/li>\n<\/ol>\n

    2012<\/b><\/p>\n

      \n
    1. Liu WH, Chen YL<\/b>, Chang LS \u201cCIL-102 induces matrix metalloproteinase-2 (MMP-2)\/MMP-9 down-regulation via simultaneous suppression of genetic transcription and mRNA stability\u201d Int. J. Biochem. Cell Biol. <\/i>2012, <\/b>44, <\/i>2212-2222. <\/i>(SCI, IF2011<\/sub> = 4.634, 67\/289 = 23.2%)<\/li>\n
    2. Tseng CH, Li CY, Chiu CC, Hu HT, Han CH, Chen YL,*<\/b> Tzeng CC* \u201cCombretastatin A-4 Derivatives: Synthesis and Evaluation of 2,4,5-Triaryl-1H<\/i>– imidazoles as Potential Agents Against H1299 (Non-small Cell Lung Cancer Cell)\u201d Mol. Divers.<\/i> 2012<\/b>, 16<\/i>(4), 697-709. (SCI, IF2011<\/sub> = 3.153, 9\/71 = 12.7%)<\/li>\n
    3. Fang YP, Wu PC, Huang YB, Tzeng CC, Chen YL<\/b>, Hung YH, Tsai MJ, Tsai YH \u201cModification of polyethylene glycol onto solid lipid nanoparticles encapsulating a novel chemotherapeutic agent (PK-L4) to enhance solubility for injection delivery\u201d Int. J. Nanomed.<\/i> 2012<\/b>, 7<\/i>, 4995-5005. (SCI, IF2011<\/sub> = 3.130; R\/C = 70\/261, \u00a0PHARMACOLOGY & PHARMACY)<\/li>\n
    4. Chang MY, Tai HY, Chen YL<\/b>, Hsu RT \u201cSynthesis of 1,3-diaryl-1H-benzo[g]indazoles\u201d Tetrohedron, <\/i>2012<\/b>, 68,<\/i> 7941-7948. (SCI, IF2011<\/sub> = 3.025, 16\/56 = 28.6%)<\/li>\n
    5. Chang MY, Wu MH, Chen YL<\/b> \u201cSynthesis of dihydrobenzoimidazo[2,1-a]isoquinolines\u201d Tetrahedron Letts.<\/i> 2012<\/b>, 53<\/i>, 4156-4160. (SCI, IF2011<\/sub> = 2.683, 19\/56 = 33.9%)<\/li>\n
    6. Chang MY, Huang YP, Lee TW, Chen YL<\/b> \u201cSynthesis of dizocilpine\u201d Tetrohedron, <\/i>2012<\/b>, 68,<\/i> 3283-3287. (SCI, IF2011<\/sub> = 3.025, 16\/56 = 28.6%)<\/li>\n
    7. Tsai YR, Huang LJ, Lee MR, Chen YL<\/b>, Kuo SC, Tzeng CC, Hsu MF, Wang JP \u201cThe signaling mechanisms mediating the inhibitory effect of TCH-1116 on formyl peptide-stimulated superoxide anion generation in neutrophils<\/a>\u201d Eur. J. Pharm. <\/i>2012<\/b>, 682,<\/i> 171-180. (SCI, IF2011<\/sub> = 2.516, 108\/261 = 41.4%)<\/li>\n
    8. Fang YP, Wu PC, Tzeng CC, Chen YL, Lin HL, Tsai YH \u201cA New Antitumor Agent, (3-chloro-7-methoxyfuro[2,3-b]-quinolin-4-yl)-(4-methoxyphenyl) amine, Loaded in Solid Lipid Nanoparticles: Characterization and Pharmacokinetics\u201d Curr. Nanosci., <\/i>2012<\/b>, 8,<\/i> 266-273. (SCI, IF2011<\/sub> = 1.776, 76\/231 = 32.9%)<\/li>\n
    9. Tseng CH, Chen YL, <\/b>Yang CL, <\/b>Cheng CM, Han CH, Tzeng CC \u201cSynthesis of 6-Substituted 9-Methoxy-11H-indeno[1,2-c]quinoline-11-one Derivatives as Potential Anticancer Agents\u201d Bioorg. Med. Chem.<\/i> 2012<\/b>, 20<\/i>, 4397-4404. (SCI, IF2011<\/sub> = 2.921, 17\/56 = 30.4%)<\/li>\n
    10. Tseng CH, Tzeng CC, Shih PK, Yang CN, Chuang YC, Peng SI, Lin CS, Wang JP, Cheng CM, Chen YL<\/b>* \u201cIdentification of Furo[3′,2′:3,4]naphtho[1,2-d<\/i>]imidazole Derivatives as Orally Active and Selective Inhibitors of \u00a0Microsomal Prostablandin E2<\/sub> Synthase-1 (mPGES-1)\u201d Mol. Divers.<\/i> 2012<\/b>, 16<\/i>, 215-229. (SCI, IF2011<\/sub> = 3.153, 9\/71 = 12.7%)<\/li>\n<\/ol>\n

      2011<\/b><\/b><\/p>\n

        \n
      1. Tseng CH, Tzeng CC, Chung KY, Kao CL, Hsu CY, Cheng CM, Hung KS, Chen YL<\/b>* \u201cSynthesis and antiproliferative evaluation of 6-aryl-11-iminoindeno[1,2-c]quinoline derivatives\u201d Bioorg. Med. Chem.<\/i> 2011<\/b>, 19<\/i>, 7653-7663. (SCI, IF2010<\/sub> = 2.978, 15\/54)<\/li>\n
      2. Chang MY, Tai HY, Chen YL<\/b> \u201cSynthesis of rodocaine.\u201d Tetrahedron <\/i>2011<\/b>, 67, <\/i>7673-7680. (SCI, IF2010<\/sub> = 3.011, 14\/56)<\/li>\n
      3. Kao CL, Tang YH, Lin YC, Chiu LT, Chen HT, Hsu SC, Hsieh KC, Lu CY, Chen YL<\/b> <\/b>\u201cCopper complex of a pyridine-modified poly(amidoamine) dendrimer as a chemical nuclease: synthetic and catalytic study.\u201d Nanomedicine<\/i> 2011<\/b>, 7<\/i>, 273-276. (SCI, IF2010<\/sub> = 6.202, 12\/160)<\/li>\n
      4. Chang MY, Lee MF, Chen YL<\/b> \u201cSynthesis of tetrahydrobenzoisoquinolinols, tetrahydropyrindines, and hexahydroquinolines from 4-aryltetrahydropyridines.\u201d <\/i>Tetrahedron <\/i>2011<\/b>, 67, <\/i>4552-4558. (SCI, IF2010<\/sub> = 3.011, 14\/56)<\/li>\n
      5. Chen YW, Chen YL<\/b>, Tseng CH, Liang CC, Yang CN, Yao YC, Lu PJ, Tzeng CC \u201cSynthesis, Pharmacokinetic, and Anticancer Evaluations of Certain 4-Anilinofuro[2,3-b<\/i>]quinoline Derivatives\u201d J. Med. Chem.<\/i> 2011<\/b>, 54<\/i>, 4446-4461. (SCI, IF2010<\/sub> = 5.207, 3\/54)<\/li>\n
      6. Chen PY, Wang TP, Chiang MY, Huang KS, Tzeng CC, Chen YL,<\/b> Wang EC \u201cEnvironmentally benign syntheses of flavanones\u201d Tetrahedron,<\/i> 2011<\/b>, 67<\/i>, 4155-4160. (SCI, IF2010<\/sub> = 3.011, 14\/56)<\/li>\n
      7. Tseng CH, Lin RW, Chen YL<\/b>, Wang GJ, Ho ML, Tzeng CC* \u201cDiscovery of Indeno[1,2-c<\/i>]quinoline Derivatives as Inhibitors of Osteoclastogenesis Induced by Receptor Activator of NF-kB Ligand (RANKL)\u201d J. Med. Chem.<\/i> 2011<\/b>, 54<\/i>, 3103-3107. (SCI, IF2010<\/sub> = 5.207, 3\/54)<\/li>\n
      8. Tseng CH, Chen YL<\/b>, Chung KY, Wang CH, Peng SI, Cheng CM, Tzeng CC* \u201cSynthesis and antiproliferative evaluation of 2,3-diarylquinoline derivatives\u201d Org. Biomol. Chem.<\/i> 2011<\/b>, 9<\/i>, 3205-3216. (SCI, IF2010<\/sub> = 3.451, 12\/56)<\/li>\n
      9. Lee CL, Huang CH, Wang HC, Chuang DW, Wu MJ, Wang SY, Hwang TL, Wu CC, Chen YL<\/b>, Chang FR, Wu YC. \u201cFirst total synthesis of antrocamphin A and its analogs as anti-inflammatory and anti-platelet aggregation agents.\u201d Org. Biomol. Chem.<\/i> 2011<\/b>, 9<\/i>, 70-73. (SCI, IF2010<\/sub> = 3.451, 12\/56)<\/li>\n<\/ol>\n

        2010<\/b><\/p>\n

          \n
        1. Su JC, Lin KL, Chien CM, Tseng CH, Chen YL<\/b>, Chang LS, Lin SR \u201cFurano-1,2-naphthoquinone inhibits EGFR signaling associated with G2\/M cell cycle arrest and apoptosis in A549 cells\u201d Cell Biochem. Funct.<\/i> 2010<\/b>, 28<\/i>, 695\u2013705. (SCI, IF2008<\/sub> = 1.515, 213\/283)<\/li>\n
        2. Chang MY, Lin CH, Chen YL<\/b>, Hsu RT, Chang CY \u201cPd2<\/sub>(dba)3<\/sub>-promoted synthesis of 3-N-substituted 4-aryl-1,2,3,6-tetrahydropyridine\u201d Tetrahedron Lett.<\/i> 2010<\/b>, 51<\/i>, 4886-4889. (SCI, IF2008<\/sub> = 2.568, 21\/55)<\/li>\n
        3. Tseng CH, Tzeng CC, Yang CL, Lu PJ, Chen HL, Li HY, Chuang YC, Yang CN, Chen YL<\/b>* \u201cSynthesis and antiproliferative evaluation of certain indeno[1,2-c<\/i>]quinoline derivatives. Part 2\u201d J. Med. Chem.<\/i> 2010<\/b>, 53, 6164-6179. (SCI, IF2009<\/sub> = 4.802, 3\/46)<\/li>\n
        4. Tseng CH, Chen YL<\/b>, Yang SH, Peng SI, Cheng CM, Han CH, Lin SR, Tzeng CC* \u201cSynthesis and antiproliferative evaluation of certain iminonaphtho[2,3-b<\/i>]furan derivatives\u201d Bioorg. Med. Chem.<\/i> 2010<\/b>, 18<\/i>, 5172-5182. (SCI, IF2009<\/sub> = 2.822, 17\/46)<\/li>\n
        5. Chiu CC,* Chen JYF, Lin KL, Huang CJ, Chen WY, Han LY, Tseng CH, Chen YL<\/b>,* Lin SR \u201cp38 MAPK and NF\u03baB pathways are involved in Naphtho[1,2-b<\/i>] furan-4,5-dione induced anti-proliferation and apoptosis of human hepatoma cells\u201d Cancer Lett.<\/i> 2010<\/b>, 295<\/i>, 92-99. (SCI, IF2009<\/sub> = 3.741, 52\/166)<\/li>\n
        6. Lin KL, Su JC, Chien CM, Tseng CH, Chen YL<\/b>, Chang LS, Lin SR\u00a0 \u201cNaphtho[1,2-b]furan-4,5-dione disrupts Janus kinase-2 and induces apoptosis in breast cancer MDA-MB-231 cells\u201d Toxicol. In Vitro, <\/i>2010<\/b>, 24<\/i>, 1158-1167. (SCI, IF2009<\/sub> = 2.060, 44\/77)<\/li>\n
        7. Chien CM, Lin KL, Su JC, Chuang PW, Tseng CH, Chen YL<\/b>, Chang LS, Lin SR \u201cNaphtho[1,2-b<\/i>]furan-4,5-dione induces apoptosis of oral squamous cell carcinoma: Involvement of EGF receptor\/PI3K\/Akt signaling pathway\u201d Eur. J. Pharmacol. <\/i>2010<\/b>, 636<\/i>, 52-58. (SCI, IF2008<\/sub> = 2.787, 78\/219)<\/li>\n
        8. Yang PM, Huang WC, Lin YC, Huang WY, Wu HA, Chen WL, Chang YF, Chou CW, Tzeng CC, Chen YL<\/b>, Chen CC \u201cLoss of IKK beta activity increases p53 stability and p21 expression leading to cell cycle arrest and apoptosis\u201d J. Cell. Mol. Med. <\/i>2010<\/b>, 14<\/i>, 687-698. (SCI, IF2008<\/sub> = 5.114, 8\/83)<\/li>\n
        9. Chang MY, Lin CH, Chen YL<\/b>, Hsu RT, Chang CY \u201cBF3<\/sub>-promoted synthesis of spiroindenyl heterocycles\u201d Tetrahedron Lett.<\/i> 2010<\/b>, 51<\/i>, 3154-3158. (SCI, IF2008<\/sub> = 2.568, 21\/55)<\/li>\n
        10. Chang MY, Lin CH, Chen YL<\/b>, Chang CY, Hsu RT \u201cBF3<\/sub>-Promoted Synthesis of Diarylhexahydrobenzo[f<\/i>]isoquinoline\u201d Org. Lett.<\/i>. 2010<\/b>, 12<\/i>, 1176-1179. (SCI, IF2008<\/sub> = 5.128, 4\/55)<\/li>\n
        11. Lu CM, Chen YL<\/b>, Chen HL, Chen CA, Lu PJ, Yang CN, Tzeng CC* \u201cSynthesis and Antiproliferative Evaluation of Certain Indolo[3,2-c<\/i>]quinoline Derivatives\u201d Bioorg. Med. Chem.<\/i> 2010<\/b>, 18<\/i>, 1948-1957. (SCI, IF2009<\/sub> = 2.822, 17\/46)<\/li>\n
        12. Su JC, Lin KL, Chien CM, Tseng CH, Chen YL<\/b>, Chang LS, Lin SR \u201cNaphtho[1,2-b]furan-4,5-dione inactivates EGFR and PI3K\/Akt signaling pathways in human lung adenocarcinoma A549 cells\u201d Life Sci.<\/i> 2010<\/b>, 86<\/i>, 207-213. (SCI, IF2008<\/sub> = 2.583, 33\/83)<\/li>\n
        13. Chang MY, Lin CH, Chen YL<\/b> \u201cSelenium dioxide-mediated methoxyhydroxylation of cyclic arylolefin\u201d Tetrahedron Lett.<\/i> 2010<\/b>, 51<\/i>, 1430-1433. (SCI, IF2008<\/sub> = 2.568, 21\/55)<\/li>\n
        14. Lin KL, Su JC, Chien CM, Tseng CH, Chen YL<\/b>,* Chang LS, Lin SR*\u00a0 \u201cNaphtho[1,2-b]furan-4,5-dione induces apoptosis and S-phase arrest of MDA-MB-231 cells through JNK and ERK signaling activation\u201d Toxicol. In Vitro, <\/i>2010<\/b>, 24<\/i>, 61-70. (SCI, IF2009<\/sub> = 2.060, 44\/77)<\/li>\n
        15. Chang FS, Chen WC, Wang CH, Tzeng CC, Chen YL<\/b>* \u201cSynthesis and antiproliferative evaluations of certain 2-phenylvinylquinoline (2-styrylquinoline) and 2-furanylvinylquinoline derivatives\u201d Bioorg. Med. Chem.<\/i> 2010<\/b>, 18<\/i>, 124-133. (SCI, IF2009<\/sub> = 2.822, 17\/46)<\/li>\n
        16. Yang CL, Tseng CH, Chen YL<\/b>, Lu CM, Kao CL, Wu MH, Tzeng CC \u201cIdentification of benzofuro[2,3-b<\/i>]quinoline derivatives as a new class of antituberculosis agents\u201d Eur. J. Med. Chem.<\/i> <\/b>2010<\/b>, 45<\/i>, <\/b>602-607. (SCI, IF2009<\/sub> = 3.269, 10\/46)<\/li>\n<\/ol>\n

          2009<\/b><\/p>\n

            \n
          1. Su JC, Lin KL, Chien CM, Lu CM, Chen YL<\/b>, Chang LS, Lin SR* \u201cNovel indoloquinoline derivative, IQDMA, induces G2\/M phase arrest and apoptosis in A549 cells through JNK\/p38 MAPK signaling activation\u201d Life Sci.<\/i> 2009<\/b>, 85,<\/i> 505-516. (SCI, IF2008<\/sub> = 2.583, 33\/83)<\/li>\n
          2. Tseng CH, Chen YL<\/b>, Chung KY, Cheng CM, Wang CH, Tzeng CC* \u201cSynthesis and antiproliferative evaluation of 6-arylindeno[1,2-c<\/i>]quinoline derivatives\u201d Bioorg. Med. Chem.<\/i> 2009<\/b>, 17<\/i>, 7465-7476. (SCI, IF2008<\/sub> = 3.078, 12\/55)<\/li>\n
          3. Wu PC, Huang YB, Chang CK, Chen YL<\/b>, Tzeng CC, Tsai YH* \u201cHighly sensitive quantitative analysis of 1-[3-(Furo[3,2-c]quinolin-4-ylamino)phenyl]-<\/li>\n<\/ol>\n

            ethanone oxime, a new antitumor agent, in rat plasma by LC with electrochemical detection\u201d Chromatographia.<\/i> 2009<\/b>, 70<\/i>, 265-269. (SCI, IF2008<\/sub> = 1.312, 44\/70)<\/p>\n

              \n
            1. Tseng CH, Lin CS, Shih PK, Tsao LT, Wang JP, Cheng CM, Tzeng CC, Chen YL*<\/b> \u201cFuro[3′,2′:3,4]naphtho[1,2-d<\/i>]imidazole Derivatives as Potential Inhibitors of Inflammatory Factors in Sepsis\u201d Bioorg. Med. Chem.<\/i> 2009<\/b>, 17<\/i>, 6773-6779. (SCI, IF2008<\/sub> = 3.078, 12\/55)<\/li>\n
            2. Hsien KC, Chen HT, Chen YC, Chen YL<\/b>, Lu CY, Kao CL* \u201cPyridoxal 5′-Phosphate Binding in Lysine-Modified PAMAM Dendrimers: A Biomimetic Approach\u201d Org. Lett.<\/i>. 2009<\/b>, 11<\/i>, 3526-3529. (SCI, IF2008<\/sub> = 5.128, 4\/55)<\/li>\n
            3. Tseng CH, Chen YL<\/b>, Lu CM, Wang CK, Tsai YT, Lin RW, Chen CF, Chang YF, Wang GJ, Ho ML, Tzeng CC* \u201cSynthesis and Anti-osteoporotic Evaluation of Certain 3-Amino-2-hydroxypropoxyisoflavone Derivatives\u201d Eur. J. Med. Chem. <\/i>2009<\/b>, 44<\/i>, <\/i>3621-3626. (SCI, IF2008<\/sub> = 2.882, 13\/40)<\/li>\n
            4. Lee CH, Hu WP, Hong CH, Yu HS, Liao WT, Chen CY, Chen YL<\/b>, Chen BH, Chen GS, Wang JJ* \u201cPyrrolo[2,1-c][1,4]benzodiazepine and indole conjugate (IN6CPBD) has better efficacy and superior safety than the mother compound DC-81 in suppressing the growth of established melanoma in vivo\u201d Chem.-Biol. Interact.<\/i>, 2009<\/b>, 180<\/i>(3), 360-367. (SCI, IF2008<\/sub> = 3.007, 18\/75)<\/li>\n
            5. Chen YL<\/b>, Chen YW, Lo WF, Kao CL, Liu YS, Yao CW, Tzeng CC* \u201cSynthesis and antimycobacterial evaluation on arylsulfonyl and arylcarbonyl derivatives of ofloxacin\u201d J. Chin. Chem. Soc.<\/i>, 2009<\/b>, 55<\/i>, 374-380. (SCI, IF2008<\/sub> = 0.770, 80\/125)<\/li>\n
            6. Huang YL, Cheng YH, Hsien KC, Chen YL<\/b>, Kao CL* \u201cConcise bromodecarboxylation of cinnamic acids to b-bromostyrenes\u201d Tetrahrdron Lett.<\/i> <\/b>2009<\/b>, 50<\/i>, 1834-1837. (SCI, IF2008<\/sub> = 2.538, 21\/55)<\/li>\n
            7. Hu WP, Liang JJ, Kao CL, Chen YC, Chen CY, Tsai FY, Wu MJ, Chang LS, Chen YL<\/b>, Wang JJ* \u201cSynthesis and antitumor activity of novel enediyne-linked pyrrolo[2,1-c][1,4]benzodiazepine hybrids\u201d Bioorg. & Med. Chem.<\/i> 2009<\/b>, 17<\/i>, 1172-1180. (SCI, IF2008<\/sub> = 3.078, 12\/55)<\/li>\n<\/ol>\n

              2008<\/b><\/p>\n

                \n
              1. Yang SH, Chien CM, Su JC, Chen YL<\/b>, Chang LS, Lin SR \u201cNovel indoloquinoline derivative, IQDMA, inhibits STAT5 signaling associated with apoptosis in K562 cells\u201d J. of Biochem.. Mol. Toxic.<\/i> 2008<\/b>, 22<\/i>, 396-404.<\/li>\n
              2. Chien CM, Yang SH, Lin KL, Chen YL<\/b>, Chang LS, Lin SR \u201cNovel indoloquinoline derivative, IQDMA, suppresses STAT5 phosphorylation and induces apoptosis in HL-60 cells\u201d Chem.-Biol. Interact.<\/i> 2008<\/b>, 176<\/i>, 40-47.<\/li>\n
              3. Tseng CH, Chen YL<\/b>, Lu PJ, Yang CN, Tzeng CC \u201cSynthesis and antiproliferative evaluation of certain indeno[1,2-c<\/i>]quinoline derivatives\u201d Bioorg. & Med. Chem.<\/i> 2008<\/b>, 16<\/i>, 3151-3162. (SCI, IF2007<\/sub> = 2.662)<\/li>\n
              4. Chen YL<\/b>, Lin HC, Yang CN, Lu PJ, Tzeng CC \u201cSynthesis and antiproliferative evaluation of 4-anilino-n-methoxyfuro[2,3-b]quinoline derivatives (n = 6, 7). Part 5\u201d Chem. & Biodiv.<\/i> 2008<\/b>, 4<\/i>, 267-278.<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

                2013 Chen YL, Tseng CH, Lo YC, Lin RW, C … \u95b1\u8b80\u5168\u6587 →<\/span><\/a><\/p>\n","protected":false},"author":18,"featured_media":0,"parent":0,"menu_order":1,"comment_status":"open","ping_status":"open","template":"onecolumn-page.php","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":""},"class_list":["post-8","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/wp.kmu.edu.tw\/yeloch\/wp-json\/wp\/v2\/pages\/8","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wp.kmu.edu.tw\/yeloch\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/wp.kmu.edu.tw\/yeloch\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/wp.kmu.edu.tw\/yeloch\/wp-json\/wp\/v2\/users\/18"}],"replies":[{"embeddable":true,"href":"https:\/\/wp.kmu.edu.tw\/yeloch\/wp-json\/wp\/v2\/comments?post=8"}],"version-history":[{"count":5,"href":"https:\/\/wp.kmu.edu.tw\/yeloch\/wp-json\/wp\/v2\/pages\/8\/revisions"}],"predecessor-version":[{"id":10,"href":"https:\/\/wp.kmu.edu.tw\/yeloch\/wp-json\/wp\/v2\/pages\/8\/revisions\/10"}],"wp:attachment":[{"href":"https:\/\/wp.kmu.edu.tw\/yeloch\/wp-json\/wp\/v2\/media?parent=8"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}